Prospect Financial Services’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Sell |
14,839
-3,490
| -19% | -$35.7K | 0.09% | 100 |
|
|
2025
Q1 | $143K | Buy |
18,329
+1,875
| +11% | +$14.6K | 0.08% | 108 |
|
|
2024
Q4 | $268K | Buy |
16,454
+1,700
| +12% | +$27.7K | 0.15% | 91 |
|
|
2024
Q3 | $561K | Buy |
14,754
+849
| +6% | +$32.3K | 0.35% | 47 |
|
|
2024
Q2 | $626K | Buy |
13,905
+262
| +2% | +$11.8K | 0.48% | 40 |
|
|
2024
Q1 | $668K | Buy |
13,643
+885
| +7% | +$43.4K | 0.55% | 39 |
|
|
2023
Q4 | $977K | Buy |
+12,758
| New | +$977K | 0.99% | 24 |
|